W. Alberto Sifuentes Giraldo: Non-Criteria Manifestations of Antiphospholipid Syndrome
W. Alberto Sifuentes Giraldo, Rheumatologist at Hospital Nuestra Señora de Sonsoles (Sacyl), shared a post on X:
”Although the classification criteria for antiphospholipid syndrome (APS) classically require the presence of a thrombotic event in the venous vascular territory (e.g., deep vein thrombosis) or arterial territory (e.g., myocardial infarction, stroke), or recurrent fetal loss, this does not mean that patients with positive antiphospholipid antibodies who do not meet these criteria do not have this disorder.
The spectrum of APS manifestations is broad and encompasses several other symptoms that are not criteria, such as cutaneous manifestations including livedo reticularis, necrotic ulcers, pseudovasculitic lesions, digital gangrene, and splinter hemorrhages, among others.
The presence of antiphospholipid antibodies can also be associated with other symptoms, such as thrombocytopenia, valvular heart disease, epilepsy, or transverse myelitis. Furthermore, it carries an increased risk of other autoimmune disorders. In half of the cases, APS is associated with other autoimmune rheumatic diseases, the most frequent being systemic lupus erythematosus.
Non-Criteria Manifestations of Antiphospholipid Syndrome (APS). Adapted from: Pires da Rosa G, Espinosa G, Cervera R.
Non-criteria manifestations of antiphospholipid syndrome: an overview. Span J Med. 2021;1(2).”
Stay updated with Hemostasis Today.
-
Jun 14, 2026, 22:49Cihan Ay: From First Oral Presentation to Pro and Con Debate – A 20-Year EHA Journey
-
Jun 14, 2026, 19:54Tareq Abadl: What Happens If You Transfuse the Wrong Blood Group?
-
Jun 14, 2026, 19:46Amber Yates: Stretching Scientific Muscles in Areas of Hematology – Day 2 at EHA 2026
-
Jun 14, 2026, 19:41Peter Loffelhardt: Thousands of People Coming in – Second Day at EHA 2026
-
Jun 14, 2026, 19:38Jecko Thachil: Can We Predict and Prevent Bleeding in APL?
-
Jun 14, 2026, 19:32Highlights from Day 1 at the EHC Leadership Conference 2026
-
Jun 14, 2026, 18:01Ahmar U. Zaidi: The First Pivotal Study of a New Mechanism in Sickle Cell Disease
-
Jun 14, 2026, 18:00Lennart Lenk: Witnessing Former Boss Deliver a Plenary Talk at EHA 2026
-
Jun 14, 2026, 18:00Priya Sriskandarajah: Great Presentations on Recent Advances in Myelofibrosis at EHA 2026